Cargando…

Improving Therapeutic Ratio in Head and Neck Cancer with Adjuvant and Cisplatin-Based Treatments

Advanced head and neck cancers are difficult to manage despite the large treatment arsenal currently available. The multidisciplinary effort to increase disease-free survival and diminish normal tissue toxicity was rewarded with better locoregional control and sometimes fewer side effects. Neverthel...

Descripción completa

Detalles Bibliográficos
Autor principal:	Marcu, Loredana G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881661/ https://www.ncbi.nlm.nih.gov/pubmed/24455727 http://dx.doi.org/10.1155/2013/817279

Ejemplares similares

Current Omics Trends in Personalised Head and Neck Cancer Chemoradiotherapy
por: Marcu, Loredana G., et al.
Publicado: (2021)

Current Role of Delta Radiomics in Head and Neck Oncology
por: Marcu, David C., et al.
Publicado: (2023)

The Promise of Novel Biomarkers for Head and Neck Cancer from an Imaging Perspective
por: Marcu, Loredana G., et al.
Publicado: (2018)

Hypoxia in Head and Neck Cancer in Theory and Practice: A PET-Based Imaging Approach
por: Marcu, Loredana G., et al.
Publicado: (2014)

Adaptive Radiotherapy in Head and Neck Cancer Using Volumetric Modulated Arc Therapy
por: Buciuman, Nikolett, et al.
Publicado: (2022)

Radiobiological modeling of interplay between accelerated repopulation and altered fractionation schedules in head and neck cancer
por: Marcu, Loredana G., et al.
Publicado: (2009)

Dosimetric justification for the use of volumetric modulated arc therapy in head and neck cancer—A systematic review of the literature
por: Buciuman, Nikolett, et al.
Publicado: (2021)

Prognostic Factors for the Therapeutic Performance of Cisplatin in Head and Neck Malignancies
por: Jungbauer, Frederic, et al.
Publicado: (2022)

Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio
por: Rooney, Michael K., et al.
Publicado: (2023)

Adjuvant chemotherapy in head and neck cancer.
por: Stell, P. M., et al.
Publicado: (1990)

MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers
por: Tolue Ghasaban, Faezeh, et al.
Publicado: (2023)

Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trial
por: Wiegand, Susanne, et al.
Publicado: (2023)

Nanoparticle-Based Targeted Therapeutics in Head-And-Neck Cancer
por: Wu, Ting-Ting, et al.
Publicado: (2015)

Influence of the human papillomavirus on the radio-responsiveness of cancer stem cells in head and neck cancers
por: Reid, Paul, et al.
Publicado: (2020)

Machine Learning–Guided Adjuvant Treatment of Head and Neck Cancer
por: Howard, Frederick Matthew, et al.
Publicado: (2020)

Multi-kinase inhibitors and cisplatin for head and neck cancer treatment in vitro
por: Brands, Roman C., et al.
Publicado: (2019)

Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells
por: Möckelmann, Nikolaus, et al.
Publicado: (2016)

A Novel Curcumin Analog (H-4073) Enhances the Therapeutic Efficacy of Cisplatin Treatment in Head and Neck Cancer
por: Kumar, Bhavna, et al.
Publicado: (2014)

Chemoradiotherapy With Generic Cisplatin Formulations for Head and Neck Cancers
por: Shimada, Rie, et al.
Publicado: (2018)

Intrinsic Radiosensitivity Is Not the Determining Factor in Treatment Response Differences between HPV Negative and HPV Positive Head and Neck Cancers
por: Reid, Paul, et al.
Publicado: (2020)

Experimental investigation of radiobiology in head and neck cancer cell lines as a function of HPV status, by MTT assay
por: Reid, Paul, et al.
Publicado: (2018)

Cisplatin-Based Chemotherapy versus Cetuximab in Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer Treatment
por: Hu, Ming-Hung, et al.
Publicado: (2014)

Treatment Considerations for Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin
por: Kim, Sangwoo S., et al.
Publicado: (2023)

Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas
por: Griso, Ana Belén, et al.
Publicado: (2022)

Identification of hub genes involved in cisplatin resistance in head and neck cancer
por: Chaudhary, Raushan Kumar, et al.
Publicado: (2023)

Clinical and Therapeutic Considerations for Older Adults with Head and Neck Cancer
por: Dickstein, Daniel R, et al.
Publicado: (2023)

Progress and challenges in the vaccine-based treatment of head and neck cancers
por: Venuti, Aldo
Publicado: (2009)

In vitro investigation of head and neck cancer stem cell proportions and their changes following X-ray irradiation as a function of HPV status
por: Reid, Paul, et al.
Publicado: (2017)

The Role of microRNA in Head and Neck Cancer: Current Knowledge and Perspectives
por: Courthod, Giulia, et al.
Publicado: (2014)

Cisplatin and paclitaxel co-delivered by folate-decorated lipid carriers for the treatment of head and neck cancer
por: Yang, Jiying, et al.
Publicado: (2017)

Imaging Biomarkers of Tumour Proliferation and Invasion for Personalised Lung Cancer Therapy
por: Marcu, Loredana G.
Publicado: (2020)

Targeting NEDDylation as a Novel Approach to Improve the Treatment of Head and Neck Cancer
por: Jones, Trace M., et al.
Publicado: (2021)

Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck Cancer
por: Whang, Sonia N., et al.
Publicado: (2015)

An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer.
por: Munro, A. J.
Publicado: (1995)

Drug resistance against 5-fluorouracil and cisplatin in the treatment of head and neck squamous cell carcinoma: A systematic review
por: Atashi, Fatemeh, et al.
Publicado: (2021)

FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin
por: McDermott, Sarah C., et al.
Publicado: (2018)

The Nephroprotective Effect of Mannitol in Head and Neck Cancer Patients Receiving Cisplatin Therapy
por: Hägerström, Erik, et al.
Publicado: (2019)

Targeting proliferation and survival pathways in head and neck cancer for therapeutic benefit
por: Johnson, Daniel E.
Publicado: (2012)

IL-6 in the Ecosystem of Head and Neck Cancer: Possible Therapeutic Perspectives
por: Španko, Michal, et al.
Publicado: (2021)

NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer
por: Bauman, Julie E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4l02r61eusmr4d854hkrv6331a